As a consultant, he has worked with numerous pharmaceutical and biotech companies to develop and support their market access and commercial strategies. And as a leader of several healthcare consulting businesses, Peter is adept at identifying ways to better serve his clients, either by enhancing current services or introducing new offerings to best meet his clients’ needs in dynamic environments.
Peters joining represents a significant moment for Deallus. We are excited to combine his breadth of experience in pharmaceutical strategy consulting with our track record in strategic intelligence, in order to provide a higher quality and enhanced service to our clients. Peter will officially join Deallus on 7 May 2019. He will be based in our London office but will travel frequently to the US, Japan, and other regions where our clients may operate.
“I am very excited about joining Deallus, a best-in-class, client-centric and pioneering company. Deallus is making a difference to its clients because of the dedication and quality of the great people that it attracts and develops. I am impressed with the Deallus brand and am honoured to be able to contribute to its continued success.” – Peter Hempshall
Jonas Pedersén will remain heavily active within Deallus as a Director, working more closely with clients to support our clients in building their internal intelligence capabilities.
“I’m thrilled to have the new CEO joining us – he will bring extremely valuable experience and expertise to the company, which in turn will drive growth and further develop a truly client-centric, top notch healthcare consultancy. I’m equally excited about the opportunity for me to focus my time and energy on what I love most – working with clients to help them tackle challenges, shape their strategy, and outmanoeuvre the competition. Deallus means the world to me, and I know that our new CEO is the right man to help our company and our people continue to grow, learn and develop!” – Jonas Pedersén
Please joining us in welcoming Peter to Deallus!